Pharmafile Logo
Pharmafocus logo
Advanced Search

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

News

Trained to win

November 13, 2006
Business Services, Sales and Marketing marketing, sales, training

Pharmaceutical sales and marketing managers have a dizzying array of training courses, educational aids and events at their disposal, all …

Feature

Genentech to buy biotech Tanox for $900 million

November 10, 2006
Sales and Marketing Genentech

 Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …

News

iPod-ready patient information leaflets coming soon

November 10, 2006
Sales and Marketing patients

From next month, patients will be able to learn about their medicines by listening to an iPod, MP3 player or …

News

Roche sponsor early breast cancer leaflet

November 10, 2006
Medical Communications

Roche is backing a new leaflet designed to help patients with newly diagnosed early breast cancer make sense of the …

News

US Democrats to target pharmaceutical prices

November 10, 2006
Sales and Marketing

 The decisive victory of the Democrat party in the US mid-term elections looks set to bring new pressure on pharmaceutical …

News

UK biotech comes to market

November 10, 2006
Research and Development biotech, investment

At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …

Feature

Sepsis drug put back at least two years

November 9, 2006
Research and Development

 AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …

News

‘Pulsed’ vitamin D drug could transform advanced prostate cancer treatment

November 9, 2006
Research and Development

American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …

News

Abbott buys cholesterol drug specialists Kos

November 9, 2006
Sales and Marketing

Abbott is to pay $3.7 billion for Kos, the specialist US pharma company which has developed a number of major …

News

Novartis to be first pharma to conduct R&D in China

November 7, 2006
Research and Development Asia, China, Novartis, em

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …

News

Once-a-day colitis drug could take on the leaders

November 7, 2006
Sales and Marketing

Shire is hoping its new, one-a-day treatment approach for ulcerative colitis (UC) will give the market leaders a run for …

News

First class relationships

November 6, 2006
Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

Pharma goes 'no frillls'Provocative headlines drawing attention to inappropriate behaviour and misconduct in the medical and pharmaceutical professions have been …

Feature

New drive to cut millions from branded sales on NHS

November 3, 2006
Sales and Marketing generics

Some of the UK's top selling medicines are to be targeted in a new NHS drive to cut millions from …

News

New clinical trials agreement to improve UK research

November 3, 2006
Research and Development

The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …

News

Teva and Schering-Plough UK to collaborate on bowel drug

November 3, 2006
Sales and Marketing

Teva has signed a deal with Schering-Plough UK to co-promote its ulcerative colitis and Crohn's disease treatment, Mesren.Teva hopes that …

News

UK industry launches ‘manifesto’ to speed uptake of new medicines

November 2, 2006
Sales and Marketing

Pharmaceutical industry organisation, the ABPI, has launched a new campaign to increase the uptake of new medicines in the UK, …

News

NHS staff unite in protest against government policies

November 1, 2006

 NHS employees from across England gathered in Westminster to protest against government reforms and cuts to the health service, which …

News

GSK suffers pipeline setbacks

November 1, 2006
Research and Development

 A series of problems with GlaxoSmithKline's late stage product pipeline has taken the shine off its third quarter figures.The company …

News

Pharma’s evolving relationship with NICE

November 1, 2006
Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026